UNSPSC 51386001: Isoprofen

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H20O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 18751GAD0P, chemically known as 2,3-dihydro-alpha-methyl-2-(1-methylethyl)-1h-indene-5-acetic acid but generally known as isoprofen, which bears US NIH Compound Identifier 68769. European Medicines Agency schedules Isoprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08331MIG. The term ISOPROFEN is an International Non-Proprietary Name.

UNSPSC 51386001 Isoprfen is a Commodity code that represents pharmaceutical products state and local governments procure for health and community health programs, though recent activity shows the code captures a broader pharmaceutical and over-the-counter (OTC) product sourcing landscape. State and local buyers under this code include county health departments, state health and human services agencies, and cooperative purchasing alliances serving multiple jurisdictions. The scope of work spans acquisition of branded and generic pharmaceuticals, OTC medications, naloxone and emergency medical supplies, and related drug-delivery systems for public health initiatives, emergency response, and institutional healthcare delivery.

Recent solicitations reflect activity across Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for quarterly delivery to the county community health building, with response due July 26, 2023 (note: date discrepancy in source). The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather vendor capabilities on direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products with March 26, 2026 response deadline, requiring vendors to supply through three authorized wholesalers (AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson) and serve participating state and local facilities across Minnesota and Oregon.